San Francisco, CA, United States of America

Olema Pharmaceuticals, Inc.


Patents = 8

Trademarks = 3

Forward Citations = 35


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


14 inventors (with patents filed for the assignee):

goldMedal David C Myles (8 out of 26 patents)

silverMedal Peter J Kushner (7 out of 17 patents)

bronzeMedal Cyrus L Harmon (7 out of 7 patents)

4 Brian R Hearn (1 out of 11 patents)

5 Susanta Samajdar (1 out of 26 patents)

6 Chandregowda Venkateshappa (1 out of 5 patents)

7 Leslie Carol Hodges Gallagher (1 out of 1 patent)

8 Kalisankar Bera (1 out of 1 patent)

9 David Yeghikyan (1 out of 1 patent)

10 Reena Chawla (1 out of 1 patent)

11 Richard Sun (1 out of 1 patent)

12 Leslie Hodges Gallagher (1 out of 1 patent)

13 Suraj Tatyasaheb Gore (1 out of 1 patent)

14 Raymond A Ng (1 out of 1 patent)


8 patents:

1. 12428379 - Acylsulfonamide KAT6A inhibitors (2025-09-30),
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer therapies. The company is dedicated to advancing precision medicine by targeting therapeutically relevant molecular pathways. Olema's pipeline includes innovative treatments for hormone receptor-positive breast cancer and other solid tumors.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

8 Patents

#522 in San Francisco, CA

#8,276 in California

#34,838 in US

...
San Francisco, CA, United States of America
Forward Citations = 35

14 inventors:

Please report any incorrect information to support@idiyas.com
Loading…